A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT04791514 · TERMINATED

Trial details

NCT number: NCT04791514
Sponsor: Insmed Incorporated
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2022-03-29
Primary completion: 2022-08-26
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.